Search results
AstraZeneca withdraws its COVID-19 vaccine from global market
The Hill via Yahoo News· 1 month agoAstraZeneca is withdrawing its COVID-19 vaccine from the market because of low demand, the drugmaker...
AstraZeneca withdraws COVID-19 vaccine, citing declining demand
BioPharma Dive via Yahoo Finance· 1 month agoThe move ends a turbulent saga for AstraZeneca, which successfully developed a coronavirus shot but...
Exclusive: AstraZeneca may not stay in vaccines, but CEO has no COVID regrets
Reuters via Yahoo News· 2 years agoAstraZeneca may not stay in the vaccine business in the long run, its CEO told Reuters on Tuesday,...
Why the U.S. Doesn’t Have a Nasal Vaccine for COVID-19
Time via Yahoo News· 2 years agoCredit - Illustration by Alex Nabaum for TIME The U.S. led the world in quickly developing COVID-19...
EU regulator backs use of Novavax COVID shot as a booster
Reuters via Yahoo News· 2 years agoThe European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a...
AstraZeneca Ditches US Application Submission For COVID-19 Shot, Q3 Edges Analyst Expectations On...
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) has reported Q3 core EPS of $1.67, up 55% Y/Y (+70 constant currency),...
Here's How Long COVID-19 Vaccine Immunity Really Lasts
Time via Yahoo News· 1 year agoCredit - Brian Cassella—Getty Images/Chicago Tribune/Tribune News Service Whether you get it from a...
With coronavirus uptick, should I get a COVID shot? When are new vaccines available?
LA Times via Yahoo News· 10 months agoThe fall vaccination season is just around the corner, and officials are rolling out a new updated...
Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval
Yahoo Finance via AOL· 2 years agoNovavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first...
Valneva Posts Additional Encouraging Data From COVID-19 Booster Trial
Benzinga via Yahoo Finance· 2 years agoAdditional readouts from Valneva SE's (NASDAQ: VALN) pivotal VLA2001-301 "Cov-Compare" trial of...